Current Guidelines
EAS publishes Guidelines together with the European Society of Cardiology and other European Societies. These fundamentally important, evidence-based articles are written by independent groups of experts, to advise clinicians on their practice.
Our current guidelines provide recommendations on cardiovascular-disease prevention, and how to manage patients with dyslipidaemias.
- 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
- 2021 European Guidelines on CVD prevention in clinical practice
- 2019 ESC/EAS Guidelines on management of dyslipidaemias
- 2016 ESC/EAS CVD prevention guidelines
- 2016 ESC/EAS dyslipidaemia guidelines
- 2012 ESC/EAS CVD prevention guidelines
- 2011 ESC/EAS dyslipidaemia guidelines
- 2007 ESC/EAS CVD prevention guidelines
- 2003 ESC/EAS CVD prevention guidelines
- 1998 ESC/EAS CVD prevention guidelines
- 1994 ESC/EAS CVD prevention guidelines
- 1988 EAS Hyperlipidaemia guidelines
- 1987 EAS CVD prevention guidelines
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
Published online August 28, 2025 in Atherosclerosis
DOI: 10.1016/j.atherosclerosis.2025.120479
Published in European Heart Journal, August 29 2025
DOI: 10.1093/eurheartj/ehaf190
2021 European Guidelines on CVD prevention in clinical practice
European Heart Journal, Volume 42, Issue 34, 7 September 2021, Pages 3227–3337
DOI: 10.1093/eurheartj/ehab484
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
Published online August 31, 2019
DOI: 10.1016/j.atherosclerosis.2019.08.014